Switch to dolutegravir is well tolerated in Thais with HIV infection

INTRODUCTION: Dolutegravir (DTG) is recommended as part of first‐line antiretroviral therapy (ART) for people living with HIV(PLHIV). We sought to determine the rate of adverse events (AEs) and discontinuations among Thais treated during acute HIV infection (AHI) and switched to DTG‐based regimens....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int AIDS Soc
Main Authors: Goh, Orlanda Q, Colby, Donn J, Pinyakorn, Suteeraporn, Sacdalan, Carlo, Kroon, Eugène, Chan, Phillip, Chomchey, Nitiya, Kanaprach, Ratchapong, Prueksakaew, Peeriya, Suttichom, Duanghathai, Trichavaroj, Rapee, Spudich, Serena, Robb, Merlin L, Phanuphak, Praphan, Phanuphak, Nittaya, Ananworanich, Jintanat
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6621926/
https://ncbi.nlm.nih.gov/pubmed/31294931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados